GILLX | VTSMX | GILLX / VTSMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 32 years | - |
Gain YTD | 16.640 | 16.884 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 351M | 1.72T | 0% |
Annual Yield % from dividends | 0.38 | 1.26 | 30% |
Returns for 1 year | 25.50 | 25.89 | 99% |
Returns for 3 years | 21.28 | 21.33 | 100% |
Returns for 5 years | 70.02 | 82.93 | 84% |
Returns for 10 years | 66.12 | 178.97 | 37% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTMCX | 24.85 | 0.02 | +0.08% |
First Trust Multi-Strategy Cl C | |||
SHPAX | 21.31 | -0.05 | -0.23% |
Saratoga Health & Biotechnology A | |||
GIDCX | 7.27 | -0.02 | -0.27% |
Goldman Sachs Intl Eq Div & Prem C | |||
TILRX | 27.40 | -0.09 | -0.33% |
Nuveen Large Cap Growth R | |||
FZABX | 28.18 | -0.15 | -0.53% |
Fidelity Advisor Diversified Intl Z |